Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation

被引:44
作者
Chaney, MA
Nikolov, MP
Blakeman, BP
Bakhos, M
Slogoff, S
机构
[1] Loyola Univ, Med Ctr, Dept Anesthesiol, Foster G McGaw Hosp, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Thorac & Cardiovasc Surg, Foster G McGaw Hosp, Maywood, IL 60153 USA
关键词
D O I
10.1016/S0003-4975(99)00067-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Whether or not methylprednisolone is beneficial during cardiac operation remains controversial. This study examines the effects of the drug on complement activation and hemodynamics in patients undergoing cardiac operation and early extubation. Methods. Patients undergoing cardiac operation were randomized to receive either intravenous methylprednisolone (group MP) or intravenous placebo (group NS). Complement 3a (C3a) levels and hemodynamic parameters were obtained perioperatively. Extubation was accomplished at the earliest clinically appropriate time. Results. Both groups exhibited equivalent increases in C3a levels after exposure to bypass. Group MP exhibited increased cardiac index, decreased systemic vascular resistance, and increased shunt flow when compared to group NS. More group MP patients required hemodynamic support and group MP patients had prolonged extubation times. Conclusions. Methylprednisolone was unable to attenuate complement activation and led to hemodynamic alterations (primarily vasodilation) that may hinder early extubation in patients after cardiac operations. (Ann Thorac Surg 1999;67:1006-11). (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1006 / 1011
页数:6
相关论文
共 24 条
[1]  
Andersen L W, 1989, J Cardiothorac Anesth, V3, P544, DOI 10.1016/0888-6296(89)90150-6
[2]   COMPLEMENT FIXATION ON CELL SURFACES BY 19S AND 7S ANTIBODIES [J].
BORSOS, T ;
RAPP, HJ .
SCIENCE, 1965, 150 (3695) :505-+
[3]   COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - QUANTITATIVE STUDY OF EFFECTS OF METHYLPREDNISOLONE AND PULSATILE FLOW [J].
BOSCOE, MJ ;
YEWDALL, VMA ;
THOMPSON, MA ;
CAMERON, JS .
BRITISH MEDICAL JOURNAL, 1983, 287 (6407) :1747-1750
[4]  
CAVAROCCHI NC, 1986, J THORAC CARDIOV SUR, V91, P252
[5]   Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation [J].
Chaney, MA ;
Nikolov, MP .
ANESTHESIA AND ANALGESIA, 1998, 87 (01) :27-33
[6]   INEFFECTIVENESS OF METHYLPREDNISOLONE IN TREATMENT OF PULMONARY DYSFUNCTION AFTER CARDIOPULMONARY BYPASS [J].
COFFIN, LH ;
SHINOZAKI, T ;
DEMEULES, JE ;
BROWDIE, DA ;
DEANE, RSD ;
MORGAN, JG .
AMERICAN JOURNAL OF SURGERY, 1975, 130 (05) :555-559
[7]  
DIETZMAN RH, 1975, J THORAC CARDIOV SUR, V69, P870
[8]   CORTICOSTEROIDS AS EFFECTIVE VASODILATORS IN TREATMENT OF LOW OUTPUT SYNDROME [J].
DIETZMAN, RH ;
CASTANEDA, AR ;
LILLEHEI, CW ;
ERSEK, RA ;
MOTSAY, GJ ;
LILLEHEI, RC .
CHEST, 1970, 57 (05) :440-+
[9]   INFLUENCE OF STEROIDS ON COMPLEMENT AND CYTOKINE GENERATION AFTER CARDIOPULMONARY BYPASS [J].
ENGELMAN, RM ;
ROUSOU, JA ;
FLACK, JE ;
DEATON, DW ;
KALFIN, R ;
DAS, D .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :801-804
[10]   EFFECTS OF METHYLPREDNISOLONE ON COMPLEMENT ACTIVATION AND LEUKOCYTE COUNTS DURING CARDIOPULMONARY BYPASS [J].
FOSSE, E ;
MOLLNES, TE ;
OSTERUD, A ;
AASEN, AO .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1987, 21 (03) :255-261